DocGo Inc.

Greetings and welcome to the DocGo second quarter 2022 earnings conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star and then zero on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Steve Halper. Please go ahead, sir.

Thank you, Irene. Before turning the call over to management, I'd like to make the following remarks concerning forward-looking statements. All statements in this conference call other than historical facts are indeed forward-looking statements. The words anticipate, believe, estimate, expect, intend, guidance, confidence, target, project, and other similar expressions are used typically to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance and may involve and are subject to certain risks and uncertainties and other factors that may affect DOTCO's business, financial condition, and other operating results. These include but are not limited to the risk factors and other qualifications contained in DOTCO's annual report on Form 10-K, quarterly reports filed on Forms 10-Q, and other reports and statements filed by DOTCO with the SEC to which your attention is directed. Actual outcomes and results may differ materially from what is expressed or implied by these forward-looking statements. In addition, today's presentation contains references to non-GAAP financial measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in our earnings release as well as in our filings with the Securities and Exchange Commission. The information contained in this call is accurate only as of the date discussed. Investors should not assume that statements will remain relevant and operative at a later time. We undertake no obligation to update any information discussed in this call in the future. At this time, it is now my pleasure to turn the call over to Mr. Stan Wachowski, CEO and co-founder of DocGo. Stan?

Thank you, Stephen, and thank you all for joining us today. The second quarter represented another period of strong operational execution. Our revenues increased 76% year-over-year to $109.5 million. Continued sales momentum and acquisition-based contributions have supported an increase in our 2022 revenue guidance to a range of $425 to $435 million, up from a previous range of $400 to $420 million. We're also raising our guidance for adjusted EBITDA to a range of 40 to 45 million compared to our original guidance of 35 to 41 million. Some of the key factors driving our continued organic growth, including the expansion of our agreements with Carnival Cruise Lines, new municipal programs in New York, new mobile health programs in Los Angeles, and expanded medical transportation business with Northwell. Our mass COVID testing revenues for the quarter were approximately 28 million and are expected to decline significantly in the third quarter. We have already begun offsetting with non-COVID related business in place, and in many cases, the customers will remain the same. An example of this in New York is our transition from mass COVID testing with a municipal client directly into providing primary care at homeless shelters or medical imaging services for that same client. In sum, we expect the transition to these new non-COVID projects to be relatively seamless with minimal impact on revenue generation. On the M&A front, we expect to increase our activity with several prospective transactions in the pipeline about which we are very excited. We continue to pursue synergistic opportunities where prospective targets may be currently outsourcing services which DACO could directly provide. This is in addition to those opportunities which open up new markets and drive enhanced profitability. Our goal is to continue utilizing a strong balance sheet and cash flow from operations to expand the breadth, depth, and profitability of the company portfolio of services. We continue to do an excellent job both securing your customers and deepening those relationships considerably over time. Last quarter, we shared the statistic that approximately 90% of Docco's revenues are generated from customers in the third, fourth, or fifth generation contract, and that trend continues today. This success has occurred across all varieties of customers, from corporations to healthcare systems and municipal accounts. This achievement speaks volumes about our ability to get our foot in the door, provide exceptional value to the customer, and grow that business substantially. We have also significantly enhanced our RFP capabilities in recent months, allowing us to actively bid on larger contracts across the country. While it is too early to quantify expectations, the pace of activity in this channel has more than tripled recently, and we anticipate a meaningful contribution from these efforts as we enter 2023. It is clear that the municipal customer segment will remain a cornerstone of our business for the foreseeable future, providing us with a stable base of revenue upon which we can build. Our direct-to-consumer and corporate health beta tests continue to provide very encouraging results. The direct-to-consumer market represents a tremendous opportunity, and we have partnered with some of the largest payers in the industry, including Aetna, Blue Cross, LA Care. We expect coordinated marketing efforts to begin with these partners in late 2022 and early 2023. One market I would like to take a moment to review in greater detail is a cruise line business, given that it represents a great business study regarding the value of down-to-earth services to the customer. Initially, we entered this market with a relatively small contract to provide COVID-related testing services to Carnival staff in early 2021. By the end of 2022, we expect to be facilitating full spectrum of standard healthcare services for doctors down to lower-level clinicians, a majority of Carnival's fleet. In 2022, we began serving two additional major cruise lines that we expect to follow a similar growth trajectory. The pace at which these initial contracts expanded highlights the attractiveness of DACO's unique model and commitment to customer service. This success is also reflected in our NPS, or Net Promoter Score, which is the gold standard of customer experience metrics. Scores are measured from a range of negative 100 to positive 100, with scores over 30 commonly viewed as good, with over 50 being considered excellent. Our Q2 mobile health NPS score was an impressive 77. which is a testament to our customer's strong perception regarding the value of DACO's service. Another example of continued business execution comes from a major hospital system in Southern California. This customer utilizes DACO's emergency room avoidance program, which attempts to mitigate unnecessary emergency room visits. With our program, we achieved a 35% reduction in ER visits, resulting in a significant financial savings for that institution, and earning bonus payments to DACO for hitting that goal. At the end of the day, our proprietary technology is the lifeblood that allows us to deliver efficient, cost-effective healthcare in a mobile setting. And we are making further substantial investments to support the next generation of functionality. At this time, I will hand it over to Anthony Capone, our president, to provide us some details on that front. Anthony?